Home / Inspections / 1112434

FDA Inspection 1112434 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3005523343

The FDA completed an inspection of Biomat USA, Inc. on December 5, 2019 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 5, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Louisville, KY (United States)

Facility

Other inspections at this facility

  • 1046158 (NAI Mon Mar 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 958048 (NAI Thu Feb 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 869226 (NAI Thu Mar 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 755349 (NAI Wed Nov 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 635273 (NAI Mon Dec 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources